Robeco Institutional Asset Management
HAE icon

Robeco Institutional Asset Management’s Haemonetics HAE Stock Holding History

Robeco Institutional Asset Management’s Portfolio HAE Stock Details HAE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-1,740
Closed -$149K – 989
2023
Q4 		$149K Sell
1,740
-2,312
-57% -$200K ﹤0.01% 928
2023
Q3 		$363K Sell
4,052
-5,148
-56% -$460K ﹤0.01% 871
2023
Q2 		$783K Hold
9,200
– – ﹤0.01% 808
2023
Q1 		$761K Buy
9,200
+5,800
+171% +$470K ﹤0.01% 809
2022
Q4 		$267K Buy
+3,400
New +$273K ﹤0.01% 901
2019
Q1 		– Sell
-203,733
Closed -$20.2M – 968
2018
Q4 		$20.2M Sell
203,733
-528
-0.3% -$55.5K 0.09% 287
2018
Q3 		$23.4M Buy
204,261
+500
+0.2% +$51.8K 0.09% 269
2018
Q2 		$18.3M Buy
+203,761
New +$17.2M 0.08% 289

Other funds holding HAE

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Robeco Institutional Asset Management's HAE Position: Q1 2024 in Review

Robeco Institutional Asset Management sold out of Haemonetics (HAE) in Q1 2024, closing a stake of 1,740 shares — an estimated $149K sold.

Robeco Institutional Asset Management first reported a position in HAE in Q2 2018 and held it in 8 quarters. The position peaked at $23.4M in Q3 2018. 298 funds tracked by Wall St. Rank hold HAE as of Q1 2024.

  • Robeco Institutional Asset Management reported no remaining Haemonetics position as of Q1 2024 after selling out during the quarter.
  • Robeco Institutional Asset Management sold 1,740 Haemonetics shares in Q1 2024, an estimated $149K.
  • Robeco Institutional Asset Management first reported a position in Haemonetics in Q2 2018 and held it in 8 quarters.
  • Robeco Institutional Asset Management's Haemonetics position peaked at $23.4M in Q3 2018.
  • 298 funds tracked by Wall St. Rank held Haemonetics as of Q1 2024.

Based on Robeco Institutional Asset Management's 13F filing for Q1 2024, filed 24 Apr 2024.